Equitable Trust’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$442K Sell
6,773
-238
-3% -$17.7K 0.02% 344
2025
Q4
$556K Sell
7,011
-875
-11% -$67K 0.02% 304
2025
Q3
$576K Buy
7,886
+1,690
+27% +$124K 0.03% 301
2025
Q2
$470K Buy
6,196
+83
+1% +$5.88K 0.02% 315
2025
Q1
$465K Sell
6,113
-630
-9% -$46.9K 0.03% 318
2024
Q4
$445K Sell
6,743
-79
-1% -$5.53K 0.02% 341
2024
Q3
$476K Buy
6,822
+475
+7% +$28.6K 0.03% 325
2024
Q2
$336K Buy
+6,347
New +$385K 0.02% 362

Other funds holding SOLV

Equitable Trust's SOLV Position: Q1 2026 in Review

Equitable Trust reduced its Solventum (SOLV) stake by 3.4% in Q1 2026, selling an estimated $17.7K and leaving 6,773 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #344.

Equitable Trust first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $576K in Q3 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Equitable Trust held 6,773 shares of Solventum worth $442K as of Q1 2026.
  • Equitable Trust sold 238 Solventum shares in Q1 2026, an estimated $17.7K.
  • Solventum made up 0.02% of Equitable Trust's portfolio in Q1 2026, its #344 holding.
  • Equitable Trust first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • Equitable Trust's Solventum position peaked at $576K in Q3 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.